Mistletoe Extract in the Palliation of End Stage Cancer
نویسنده
چکیده
In the end stage cancer patients where in the cure is an obligate failure necessitates the palliation approach which focuses on creating an easy and comfort life to the patient rather than treating them as an experimental model for the research [1]. Palliation approach would help in the quality improvement of the end stage life whose recovery cannot be expected. Various palliation therapies have been developed which can mentally support the well-being of the victim. Massage is also proved to be the better approach in some of the diseases. The current work is an approach where in the use of mistletoe extract in various concentrations has been used towards reaching the goal [2]. Several studies provide the beneficial effects of the mistletoe and its palliation effect. The present work aimed towards analysing the palliation of cancer symptoms like Pain, Anorexia and Insomnia etc. Whose treatment would bring back the Psychological strength and general immunity of the patient? The study is based on the use of a treatment methodology which emphasizes on maintaining the patients mental condition and peace by controlling or totally preventing the side effects. Apart from its pathogenic activity, the new scientific era has revealed its importance in the treatment of cancer this breakthrough in the history of cancer therapy. There are very few side effects which may be caused by the use of mistletoe extract [3-8]. The inherent nature of this extract can provide a soothing effect for the patients thereby maintaining a pleasant environment for the patient. Palliation therapy focuses on the psychological effect of the patient rather than the metabolic change.
منابع مشابه
Cytotoxic Effects of Iranian Mistletoe Extract on a Panel of Cancer Cells
Extracts derived from Viscum album have been shown to kill cancer cells in vitro. Some studies have noted that different species of this plant collected from around the world displayed cytotoxic effects in different extents. In the present study, we evaluated the effects of Iranian mistletoe extracts on five cancer cell lines. Plants growing on hornbeam tree (Carpinus...
متن کاملProduction, Quality Control and Pharmacokinetic Studies of 177Lu-EDTMP for Human Bone Pain Palliation Therapy Trials
Developing new bone pain palliation agents is a mandate in handling end-stage cancer patients around the world. Possibly, Lu-177 ethylenediaminetetramethylene phosphonic acid (177Lu-EDTMP) is a therapeutic agent which can be widely used in bone palliation therapy. In this study, 177Lu-EDTMP complex was prepared successfully using synthesized EDTMP ligand and 177LuCl3. Lu-177 chloride was obt...
متن کاملProduction, Quality Control and Pharmacokinetic Studies of 177Lu-EDTMP for Human Bone Pain Palliation Therapy Trials
Developing new bone pain palliation agents is a mandate in handling end-stage cancer patients around the world. Possibly, Lu-177 ethylenediaminetetramethylene phosphonic acid (177Lu-EDTMP) is a therapeutic agent which can be widely used in bone palliation therapy. In this study, 177Lu-EDTMP complex was prepared successfully using synthesized EDTMP ligand and 177LuCl3. Lu-177 chloride was obt...
متن کاملErratum to “NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors”
PURPOSE European Mistletoe (Viscum album L.) extracts (mistletoe) are commonly used for cancer treatment in Europe. This phase I study of gemcitabine (GEM) and mistletoe in advanced solid cancers (ASC) evaluated: (1) safety, toxicity, and maximum tolerated dose (MTD), (2) absolute neutrophil count (ANC) recovery, (3) formation of mistletoe lectin antibodies (ML ab), (4) cytokine plasma concentr...
متن کاملRadionuclide Treatment with 153Sm-EDTMP is Effective for the Palliation of Bone Pain in the Context of Extensive Bone Marrow Metastases: A Case Report
Radionuclide therapy is widely used as an effective modality in the management of bone pain. The main indication for this treatment is symptomatic bone metastases, confirmed by bone scintigraphy. We present a case of small cell lung cancer (SCLC) stage T4N2M1b, with a good metabolic response to systemic therapy and radiotherapy of the primary tumor and locoregional disease, which became metabol...
متن کامل